Subscription rights in Medical Prognosis Institute A/S will be admitted to trading on First North as per 17 September 2014. As of the same date, ISIN DK0060514487 (MPI) will be traded exclusive of subscription rights.
| ISIN: | DK0060571792 |
| Name: | Medical Prognosis Institute, T-ret |
| Proportion: |
1:10 Shareholders in Medical Prognosis Institute A/S will have the right to subscribe for 1 new share per 10 existing shares 10 subscription rights are needed to subscribe for 1 new share |
| Trade in subscription rights (both days included): | 17 September 2014 to 30 September 2014 |
| Orderbook ID: | 102701 |
| Short name: | MPI T |
| Market Segment / no | First North / 100 |
| Tick Size /no | XCSE Equities, DKK / 7 |
| MIC Code | XFND |
Medical Prognosis Institute makes a rights issue of up to 104,064 new each bearing a face value of DKK 1. Subscription price is fixed at DKK 180 per share of DKK 1.Subscription period: 22 September to 3 October 2014, both days inclusive.
Please note:
Subscription of new shares from the rights issue will take place in a temporary ISIN (DK0060571875) which will not be admitted to trading on First North. The new shares will be traded in the existing ISIN DK0060514487after the registration of the new shares with the Danish Business Authority.
This information is distributed at the request of the Certified Advisor, PwC.
For further information, please call PwC on +45 39 45 39 45.
